Bank of America’s TriSalus Life Sciences TLSI Stock Holding History

Bank of America’s Portfolio TLSI Stock Details TLSI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$934K	Buy	205,342 +3,623	+2%	+$14.4K	﹤0.01%	4641
2026 Q1	$807K	Buy	201,719 +3,703	+2%	+$18.1K	﹤0.01%	4629
2025 Q4	$1.38M	Buy	198,016 +8,836	+5%	+$49.5K	﹤0.01%	4331
2025 Q3	$880K	Buy	189,180 +274	+0.1%	+$1.28K	﹤0.01%	5413
2025 Q2	$1.03M	Buy	188,906 +3,374	+2%	+$18.1K	﹤0.01%	5283
2025 Q1	$1.02M	Buy	185,532 +7,086	+4%	+$37.7K	﹤0.01%	5199
2024 Q4	$894K	Buy	178,446 +178,298	+120,472%	+$753K	﹤0.01%	5126
2024 Q3	$682	Buy	148 +48	+48%	+$254	﹤0.01%	7318
2024 Q2	$552	Sell	100 -2,068	-95%	-$17.5K	﹤0.01%	7339
2024 Q1	$21.1K	Buy	+2,168	New	+$20K	﹤0.01%	6744
2022 Q4	–	Sell	-700,000	Closed	-$6.95M	–	8438
2022 Q3	$6.95M	Hold	700,000	–	–	﹤0.01%	2996
2022 Q2	$6.89M	Buy	+700,000	New	+$6.88M	﹤0.01%	3057

Other funds holding TLSI

FLAM

First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Cerity Partners New York $82.7B AUM 28.53% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return

GGHC

Gilder Gagnon Howe & Co New York $9.69B AUM 55.7% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

WPC

White Pine Capital Bloomington, Minnesota $423M AUM 67.01% 1-Year Est. Return

TSW

Thompson Siegel & Walmsley Richmond, Virginia $5.57B AUM 9.46% 1-Year Est. Return

Bank of America's TLSI Position: Q2 2026 in Review

Bank of America increased its TriSalus Life Sciences (TLSI) stake by 1.8% in Q2 2026, buying an estimated $14.4K and bringing the position to 205,342 shares worth $934K. The position accounts for ﹤0.01% of the portfolio, ranked #4641.

Bank of America first reported a position in TLSI in Q2 2022 and has held it in 12 quarters since. The position peaked at $6.95M in Q3 2022. 79 funds tracked by Wall St. Rank hold TLSI as of Q2 2026.

Bank of America held 205,342 shares of TriSalus Life Sciences worth $934K as of Q2 2026.
Bank of America bought 3,623 TriSalus Life Sciences shares in Q2 2026, an estimated $14.4K.
TriSalus Life Sciences made up ﹤0.01% of Bank of America's portfolio in Q2 2026, its #4641 holding.
Bank of America first reported a position in TriSalus Life Sciences in Q2 2022 and has held it in 12 quarters since.
Bank of America's TriSalus Life Sciences position peaked at $6.95M in Q3 2022.
79 funds tracked by Wall St. Rank held TriSalus Life Sciences as of Q2 2026.

Based on Bank of America's 13F filing for Q2 2026, filed 14 Aug 2026.